Report of Foreign Issuer (6-k)
January 06 2020 - 10:59AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of January 2020
Commission
File Number 333-209744
TODOS
MEDICAL LTD.
(Translation
of registrant's name into English)
1
Hamada Street
Rehovot,
Israel 2244427
Tel:
(011) (972) 8-633-3964
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form
20-F ☐ Form 40-F
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Departure
of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Appointment
of New Directors and Officers
On January 5, 2020, Todos Medical Ltd.
(the “Company”) appointed Mr. Gerald Commissiong as Chief Executive Officer (CEO) and Director of the Company. In addition,
Mr. Daniel Hirsch was promoted to Chief Financial Officer and appointed a Director of the Company on January 5, 2020. Mr. Hirsch
previously served as the Company’s Director of Investor Relations. Mr. Commissiong and Mr. Hirsch were appointed primarily
to transition the Company’s headquarters from Israel to the United States.
Dr.
Herman Weiss, an existing director of the Company, was appointed Chairman of the Board.
Mr.
Commissiong is currently a director and President & CEO of Amarantus Bioscience Holdings, Inc. and is interim-CEO of Breakthrough
Diagnostics, Inc., Todos’ joint venture with Amarantus. Mr. Commissiong has been responsible for Amarantus’ strategic
transactions, licensing, research collaborations, mergers & acquisitions in therapeutics and diagnostics, as well as fund
raising, having raised over of $50 million since inception. Prior to co-founding Amarantus, Mr. Commissiong played professional
football for the Calgary Stampeders of the Canadian Football League. Mr. Commissiong received a B.Sc. in Management Science and
Engineering with a focus on Financial Decisions from Stanford University.
Resignation
of Officer
Concurrent
with Gerald Commissiong’s appointment as CEO, Dr. Herman Weiss resigned as CEO of the Company and will focus solely on his
new role as Chairman of the Board of Directors.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
TODOS
MEDICAL LTD.
|
|
|
|
By:
|
/s/ Gerald
Commissiong
|
|
|
Name:
Gerald Commissiong
|
|
|
Title:
Chief Executive Officer
|
|
|
|
Date:
January 6, 2020
|
|
|
|
|
|
-2-
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Apr 2023 to Apr 2024